Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
John R. Petrie, Nish Chaturvedi, Ian Ford, et al.
The Lancet Diabetes & Endocrinology (2017) Vol. 5, Iss. 8, pp. 597-609
Open Access | Times Cited: 309

Showing 1-25 of 309 citing articles:

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4264
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021

Diabetes Care (2020) Vol. 44, Iss. Supplement_1, pp. S111-S124
Open Access | Times Cited: 890
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

Diabetes Care (2019) Vol. 43, Iss. Supplement_1, pp. S98-S110
Open Access | Times Cited: 865
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019

Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S90-S102
Open Access | Times Cited: 688
8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018

Diabetes Care (2017) Vol. 41, Iss. Supplement_1, pp. S73-S85
Closed Access | Times Cited: 674
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S140-S157
Open Access | Times Cited: 663
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
Yi Tan, Zhiguo Zhang, Chao Zheng, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 585-607
Open Access | Times Cited: 554
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 10, pp. 569-589
Closed Access | Times Cited: 524
Cellular and Molecular Mechanisms of Metformin Action
Traci E. LaMoia, Gerald I. Shulman
Endocrine Reviews (2020) Vol. 42, Iss. 1, pp. 77-96
Open Access | Times Cited: 514
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
R. I. G. Holt, J. Hans DeVries, Amy Hess-Fischl, et al.
Diabetes Care (2021) Vol. 44, Iss. 11, pp. 2589-2625
Open Access | Times Cited: 433
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 1, pp. 5-115
Open Access | Times Cited: 376
Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
Satish K. Garg, Robert R. Henry, Phillip Banks, et al.
New England Journal of Medicine (2017) Vol. 377, Iss. 24, pp. 2337-2348
Open Access | Times Cited: 355
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022

Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S125-S143
Closed Access | Times Cited: 337
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk
Peter Willeit, Lena Tschiderer, Elias Allara, et al.
Circulation (2020) Vol. 142, Iss. 7, pp. 621-642
Open Access | Times Cited: 334
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S158-S178
Open Access | Times Cited: 314
ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents
Andrew T. Hattersley, Siri Atma W. Greeley, Michel Polak, et al.
Pediatric Diabetes (2018) Vol. 19, pp. 47-63
Open Access | Times Cited: 281
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
Paresh Dandona, Chantal Mathieu, Moshe Phillip, et al.
The Lancet Diabetes & Endocrinology (2017) Vol. 5, Iss. 11, pp. 864-876
Open Access | Times Cited: 258
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
R. I. G. Holt, J. Hans DeVries, Amy Hess-Fischl, et al.
Diabetologia (2021) Vol. 64, Iss. 12, pp. 2609-2652
Open Access | Times Cited: 241
New Frontiers in the Treatment of Type 1 Diabetes
Jeremy Warshauer, Jeffrey A. Bluestone, Mark S. Anderson
Cell Metabolism (2019) Vol. 31, Iss. 1, pp. 46-61
Open Access | Times Cited: 200
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
John B. Buse, Satish K. Garg, Julio Rosenstock, et al.
Diabetes Care (2018) Vol. 41, Iss. 9, pp. 1970-1980
Open Access | Times Cited: 193
Metformin: Is it a drug for all reasons and diseases?
Chris R. Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Metabolism (2022) Vol. 133, pp. 155223-155223
Open Access | Times Cited: 182
Metformin Restores Tetracyclines Susceptibility against Multidrug Resistant Bacteria
Yuan Liu, Yuqian Jia, Kangni Yang, et al.
Advanced Science (2020) Vol. 7, Iss. 12
Open Access | Times Cited: 170
ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents
Siri Atma W. Greeley, Michel Polak, Pål R. Njølstad, et al.
Pediatric Diabetes (2022) Vol. 23, Iss. 8, pp. 1188-1211
Open Access | Times Cited: 110
Obesity in people living with type 1 diabetes
Bart Van der Schueren, Darcy Ellis, Raquel N. Faradji, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 776-785
Open Access | Times Cited: 105
Current and future therapies for type 1 diabetes
Bernt Johan von Scholten, Frederik Flindt Kreiner, Stephen Gough, et al.
Diabetologia (2021) Vol. 64, Iss. 5, pp. 1037-1048
Open Access | Times Cited: 104
Page 1 - Next Page

Scroll to top